Helius Medical Technologies, Inc. Class A Common Stock (DE)
HSDT US42328V6039
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Andreeff Dane CEO |
8.10 USD |
2,827 Bought |
22,885 USD |
14/12/2023 | 14/12/2023 |
Andreeff Dane CEO |
8.10 USD |
1,603 Bought |
12,976 USD |
14/12/2023 | 14/12/2023 |
Andreeff Dane CEO |
8.10 USD |
570 Bought |
4,614 USD |
14/12/2023 | 14/12/2023 |
Andreeff Dane CEO |
6.45 USD |
643 Bought |
4,146 USD |
30/11/2023 | 01/12/2023 |
Andreeff Dane CEO |
6.45 USD |
1,134 Bought |
7,312 USD |
30/11/2023 | 01/12/2023 |
Andreeff Dane CEO |
6.45 USD |
229 Bought |
1,477 USD |
30/11/2023 | 01/12/2023 |
Andreeff Dane CEO |
6.37 USD |
1,131 Bought |
7,205 USD |
30/11/2023 | 30/11/2023 |
Andreeff Dane CEO |
6.37 USD |
641 Bought |
4,083 USD |
30/11/2023 | 30/11/2023 |
Andreeff Dane CEO |
6.37 USD |
228 Bought |
1,452 USD |
30/11/2023 | 30/11/2023 |